The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
BioLineRx Ltd(NASDAQ:BLRX)

BioLineRx Ltd., a clinical-stage biopharmaceutical development company, focuses on oncology. Its development pipeline consists of clinical-stage therapeutic candidates, which include BL-8040, a peptide for the treatment of solid tumors, hematological malignancies, and stem cell mobilization; AGI-134...
Website: http://www.biolinerx.com
Founded: 2003
Full Time Employees: 42
Sector: Healthcare
Industry: Biotechnology
BioLineRx Days Payable Outstanding ttm (DPO)
BioLineRx Days Receivable Outstanding ttm (DSO)
BioLineRx Days Inventory Outstanding ttm (DIO)
BioLineRx Op Cashflow Per Share ttm
BioLineRx Free Cashflow Per Share ttm
BioLineRx Cash Per Share ttm
BioLineRx P/S ratio ttm
BioLineRx (GAAP) P/E ratio ttm
BioLineRx P/B ratio ttm
No extra charts and metrics for this ticker.